Use of a TRPC channel for the treatment of a cardiovascular disease

Details for Australian Patent Application No. 2005324908 (hide)

Owner Sanofi-Aventis

Inventors Struebing, Carsten

Agent Watermark

Pub. Number AU-B-2005324908

PCT Pub. Number WO2006/074802

Priority 05000440.7 12.01.05 EP

Filing date 23 December 2005

Wipo publication date 20 July 2006

Acceptance publication date 24 March 2011

International Classifications

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

Event Publications

9 August 2007 PCT application entered the National Phase

  PCT publication WO2006/074802 Priority application(s): WO2006/074802

29 July 2010 Alteration of Name

  The name of the applicant has been altered to Sanofi-Aventis

24 March 2011 Application Accepted

  Published as AU-B-2005324908

21 July 2011 Standard Patent Sealed

19 July 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005324915-Composite materials containing carbon nanoparticles

2005324905-5-pyrrolidinylsulfonyl isatin derivatives